Obeticholic Acid-d₄

Name: Obeticholic Acid-d 4
Brand: MedChemExpress
SKU: HY-12222S1
Rating: 4.5 (1 reviews)

Cat. No.: HY-12222S1 Purity: ≥98.0%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Obeticholic Acid-d₄ is the deuterium labeled Obeticholic acid. Obeticholic acid (INT-747) is a potent, selective and orally active FXR agonist with an EC50 of 99 nM. Obeticholic acid has anticholeretic and anti-inflammation effect. Obeticholic acid also induces autophagy[1][2][3].

For research use only. We do not sell to patients.

Obeticholic Acid-d<sub>4</sub> Chemical Structure

Obeticholic Acid-d₄ Chemical Structure

Size	Price	Stock	Quantity
1 mg	USD 665	In-stock	Estimated Time of Arrival: December 31
5 mg		Get quote
10 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Obeticholic Acid-d₄:

Obeticholic acid In-stock
Obeticholic acid-d₅ Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

410.62

Formula

C₂₅H₃₈D₄O₄

Unlabeled CAS

459789-99-2

Appearance

Solid

Color

White to off-white

SMILES

C[C@@]([C@]1([H])[C@@H](C)[C@H]2O)(CC([2H])([2H])[C@@H](O)C1([2H])[2H])[C@]3([H])[C@]2([H])[C@@](CC[C@]4([H])[C@H](C)CCC(O)=O)([H])[C@]4(C)CC3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL (243.53 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : ≥ 50 mg/mL (121.77 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.4353 mL	12.1767 mL	24.3534 mL
5 mM	0.4871 mL	2.4353 mL	4.8707 mL
10 mM	0.2435 mL	1.2177 mL	2.4353 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: ≥98.0%

Select Batch:

Data Sheet (275 KB) SDS (251 KB)

COA (252 KB)

Handling Instructions (2659 KB)

References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]

[2]. Pellicciari R, et al. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem. 2002 Aug 15;45(17):3569-72. [Content Brief]

[3]. Fiorucci S, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther. 2005 May;313(2):604-12. [Content Brief]

[4]. Ghebremariam YT, et al. FXR agonist INT-747 upregulates DDAH expression and enhances sensitivity in high-salt fed Dahl rats. PLoS One. 2013 Apr 4;8(4):e60653. [Content Brief]

[5]. Verbeke L, et al. The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. Am J Pathol. 2015 Feb;185(2):409-19. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

Ethanol / Ethanol / DMSO / DMSO	1 mM	2.4353 mL	12.1767 mL	24.3534 mL	60.8835 mL
	5 mM	0.4871 mL	2.4353 mL	4.8707 mL	12.1767 mL
	10 mM	0.2435 mL	1.2177 mL	2.4353 mL	6.0884 mL
	15 mM	0.1624 mL	0.8118 mL	1.6236 mL	4.0589 mL
	20 mM	0.1218 mL	0.6088 mL	1.2177 mL	3.0442 mL
	25 mM	0.0974 mL	0.4871 mL	0.9741 mL	2.4353 mL
	30 mM	0.0812 mL	0.4059 mL	0.8118 mL	2.0295 mL
	40 mM	0.0609 mL	0.3044 mL	0.6088 mL	1.5221 mL
	50 mM	0.0487 mL	0.2435 mL	0.4871 mL	1.2177 mL
	60 mM	0.0406 mL	0.2029 mL	0.4059 mL	1.0147 mL
	80 mM	0.0304 mL	0.1522 mL	0.3044 mL	0.7610 mL
	100 mM	0.0244 mL	0.1218 mL	0.2435 mL	0.6088 mL